We are researchers and investigators at sarcoma centers working together with pharmaceutical and biotech companies to achieve breakthroughs in sarcoma – to help improve patient outcomes, and ultimately find a cure.

The SARC organization is set up as a directorship, and the organization’s overall strategy and policy is guided by members of the board. Our scientific platform is established by leaders who are recognized experts in sarcoma research. Within this organizational structure we are positioned to bring together the range of expertise needed to move the science of sarcoma forward to develop new and better treatments for patients with sarcoma.

Staff
Board of Directors
Scientific Steering Committee
Discovery/Translation Committee
Clinical Trialist Development Committee and Local Control Working Group
Multidisciplinary Tumor Board
Research Advocacy Council

Staff

The team of individuals at SARC’s operations office provides the range of expertise needed to support the organization’s scientific leadership and sustain the infrastructure necessary to facilitate the conduct of research.

Meghan Blalock

Research Project Manager

Read Bio
Caralynn Hampson

Caralynn Hampson

Project Coordinator

Sarcoma Survivor
Read Bio
Claudia Hill

Claudia Hill

Director of Business Operations

Read Bio
Erin Kozlowski

Erin Kozlowski, MSA CCRP

Senior Research Project Manager

Read Bio
Lindsey Overman

Lindsey Overman, MS CCRP

Research Project Manager

Read Bio

Angel Funk, MPA

Development Associate

Read Bio
Lori Smith

Lori Smith

Director of Finance

Read Bio

Kimberlee Ward, MA

Administrative Associate

Read Bio
Steven W. Young

Steven Young

President & CEO, SARC

Read Bio

Board of Directors

Under the guidance of the Board of Directors, SARC’s policies and strategies are established and refined on a regular basis. Our board consists of individuals from a range of backgrounds and areas of expertise to ensure that different viewpoints are represented as strategies are crafted to support SARC’s mission. The board meets quarterly, and as needed, to conduct the important business of SARC.

Ernest “Chappie” Conrad II

Ernest “Chappie” Conrad III, MD

Chair of the Board, SARC

McGovern Medical School, The University of Texas Health Science Center at Houston
Read Bio
Eva Gallagher

Eva Gallagher, PhD

Vice Chair of the Board, SARC

Agios Pharmaceuticals; Georgetown University
Read Bio

Ann Graham

Founder/Executive Director of MIB Agents
Read Bio

John Hopper, MBA

Corporate Treasurer, SARC

Founding Co-Chair of the GI Cancers Alliance, Founding Co-Chair of NORD Rare Cancer Coalition, President Emeritus of the Fibrolamellar Cancer Foundation
Read Bio

Timothy Timmerman

Tax Department, Cardinal Health
Read Bio
Andrew Wagner

Andrew J. Wagner, MD PHD

Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute
Read Bio
Thomas Williams

Thomas Williams, PHD

Senior Operational Psychologist, NASA
Read Bio
Steven W. Young

Steven Young

President & CEO, SARC

Read Bio

Scientific Steering Committee

The Scientific Steering Committee (SSC) serves as the executive, multidisciplinary, scientific and clinical team guiding SARC’s research priorities and course. The SSC advises on the gamut of SARC programs. Further, the SSC evaluates external proposals for new clinical trials and post-hoc proposals for use of biomaterials, imaging studies, and/or clinical data from previous trials. In addition, the SSC collaborates with the SARC Discovery/Translation Committee in creating agendas for SARC conferences

Karla Ballman

Karla Ballman, PhD

Mayo Clinic
Read Bio
Janai R. Carr-Ascher

Janai R. Carr-Ascher, MD PhD

UC Davis Health Medical Center
Read Bio

Sandra D’Angelo, MD

Memorial Sloan Kettering Cancer Center
Read Bio

Lara Davis, MD

Oregon Health & Science University
Read Bio

Jonathan Fletcher, MD

Chief Scientific Officer, SARC

Harvard Medical School, Brigham and Women’s Hospital, Dana-Farber Cancer Institute
Read Bio
Anusha Kalbasi

Anusha Kalbasi, MD

Scientific Steering Committee and Local Control Working Group

Stanford University
Read Bio

Scott Okuno, MD

Chief Medical Officer, SARC

Mayo Clinic
Read Bio
Shreyaskumar Patel

Shreyaskumar Patel, MD

University of Texas MD Anderson Cancer Center
Read Bio
Jason Sicklick

Jason Sicklick, MD FACS

UC San Diego Health
Read Bio
Andrew Wagner

Andrew J. Wagner, MD PHD

Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute
Read Bio

Discovery/Translation Committee

The Discovery/Translation Committee’s mandate is to expand SARC’s commitment to mechanistic and translational sarcoma science. One of the Committee’s goals is to integrate cutting edge biomarkers and discovery science in SARC clinical trials, seeking to understand why new therapies help some people and not others. Another commitment is organizing sarcoma science working groups and conferences for sarcoma investigators in basic or translational research fields. These efforts complement and intersect with SARC’s core commitment to clinical investigation in sarcoma.

Ping Chi

Ping Chi, MD PHD

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
Read Bio
Liz Demicco

Liz Demicco, MD PHD

Department of Laboratory Medicine & Pathobiology, University of Toronto
Read Bio

Lillian Guenther, MD

Division of Molecular Oncology, St. Jude Children's Research Hospital
Read Bio

Jonathan Fletcher, MD

Chief Scientific Officer, SARC

Harvard Medical School, Brigham and Women’s Hospital, Dana-Farber Cancer Institute
Read Bio
Kevin Jones

Kevin Jones, MD PhD

Sarcoma Disease Center, Sarcoma Department of Orthopaedics, Hunstman Cancer Center
Read Bio
Troy McEachron

Troy McEachron, PhD

Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health
Read Bio
Sethe Pollack

Seth Pollack, MD

Lurie Cancer Center, Northwestern University
Read Bio
Christine Pratalis

Christine Pratilas, MD

Pediatrics & Cellular and Molecular Medicine, John Hopkins University School of Medicine
Read Bio
Joanna Przybyl

Joanna Przybyl, PhD

McGill University
Read Bio
Danh Truong

Danh Truong, PhD

Instructor

Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center
Read Bio
Keila Torres

Keila Torres, MD PhD MBA FACS

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center
Read Bio
Matt van de Rijn

Matt van de Rijn, MD PhD

Pathology, Stanford University School of Medicine, Ludwig Cancer Center
Read Bio
Andrew Wagner

Andrew J. Wagner, MD PHD

Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute
Read Bio
Brigitte Widemann

Brigitte Widemann, MD

Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health
Read Bio

Clinical Trialist Development Committee & Local Control Working Group

The purpose of SARC’s Clinical Trialist Development Committee & Local Control Working Group is to generate Sarcoma clinical trial proposals, to support young investigators in developing and submitting trials concepts, and to engage clinical trialists and industry to pursue clinical trials in sarcoma.

Samantha Armstrong, MD

Indiana University
Read Bio

Sant Chawla, MD

Sarcoma Oncology Center
Read Bio
Gregory Cote

Gregory Cote, MD PHD

* Co-Chair

Massachusetts General Hospital
Read Bio

Sandra D’Angelo, MD

Memorial Sloan Kettering Cancer Center
Read Bio

Elizabeth Davis, MD

* Co-Chair

Vanderbilt University Medical Center
Read Bio

Lara Davis, MD

Oregon Health & Science University
Read Bio

Scott Okuno, MD

Chief Medical Officer, SARC

Mayo Clinic
Read Bio

Brian Van Tine, MD PhD

* Co-Chair

Washington University
Read Bio
Anna Chalmers

Anna Chalmers, MD

Local Control Working Group

Drexel University
Read Bio
Anusha Kalbasi

Anusha Kalbasi, MD

Scientific Steering Committee and Local Control Working Group

Stanford University
Read Bio

David Konieczkowski, MD PHD

Local Control Working Group

James Cancer Hospital
Read Bio

Multidisciplinary Tumor Board

The SARC Multidisciplinary Tumor Board (SMTB) is a team of experts from a wide range of specialties that meet monthly for in-depth, evidence-based discussion of tumor diagnosis and management. More about SMTB

Kenneth Cardona

Kenneth Cardona, MD FACS

Winship Cancer Institute, Emory University
Read Bio
Ernest “Chappie” Conrad II

Ernest “Chappie” Conrad III, MD

Chair of the Board, SARC

McGovern Medical School, The University of Texas Health Science Center at Houston
Read Bio

Gina D’Amato, MD

SMTB Facilitator

Sylvester Comprehensive Cancer Center, University of Miami
Read Bio
John M. Gross

John M. Gross, MD MS

Johns Hopkins Medicine
Read Bio

Ajay Gupta, MD MS

Roswell Park Comprehensive Cancer Center
Read Bio
Matthew Houdek

Matthew Houdek, MD

Mayo Clinic
Read Bio
James Jelinek, MD

James Jelinek, MD FACR

MedStar Washington Hospital Center, MedStar National Rehabilitation Hospital
Read Bio
Alessandra Maleddu, MD

Alessandra Maleddu, MD

University of Colorado Anschutz Medical Campus
Read Bio

Scott Okuno, MD

Chief Medical Officer, SARC

Mayo Clinic
Read Bio
Dennis Pribat, MD

Dennis Priebat, MD

MedStar Washington Hospital Center and Georgetown/Lombardi Cancer Center
Read Bio
Dian Wang

Dian Wang, MD PhD

Rush Medical College
Read Bio

Research Advocacy Council

The SARC Research Advocacy Council (RAC) was created using the model established by the National Cancer Institute (NCI) for engagement of patient advocates to become “research advocates” across four key functions: advise, design, review, and disseminate. A number of individual patient advocates have agreed to serve as research advocates on the SARC Research Advocacy Council. The council convenes regularly to explore opportunities to interface with researchers. More about RAC

Annie Achee

President, National Leiomyosarcoma Foundation
Read Bio
Mitch Achee

Mitch Achee, MD

Retired Radiologist; Leiomyosarcoma Survivor, National Leiomyosarcoma Foundation
Read Bio
Felice Adler

Felice Adler, MD

Clinical Professor of Pediatrics & Advocate, University of California Irvine; Advocate, Ewing's Sarcoma Cure Coalition, Rutledge Foundation, St. Baldrick's Foundation
Read Bio
Caralyn DeWalt

Carolyn DeWalt

Advocacy and Engagement Specialist for the Life Raft Group.
Read Bio
Lisa De Young

Lisa De Young

Patient Liaison & Administrator, Sarcoma Coalition; International EHE Support Group
Read Bio
Peter Fantozzi

Peter Fantozzi

Patient Advocate & Representative, Northwest Sarcoma Foundation
Read Bio
Caralynn Hampson

Caralynn Hampson

Project Coordinator

Sarcoma Survivor
Read Bio
Jeff Kramer

Jeffrey T. Kramer, MS

President, Chondrosarcoma Foundation
Read Bio
Meegs Lund

Meegs Lund

Sarcoma Survivor
Read Bio
Rita Pecuch

Rita Pecuch

Caregiver/Patient Advocate
Read Bio

Allison Sole

Director of Biomedical Programs, Slifka Foundation
Read Bio
Val Stevenson

Val Stevenson

Caregiver/Patient Advocate
Read Bio
Lennie Woods

Lennie Woods

Co-Founder & Executive Director, Clear Cell Sarcoma Foundation
Read Bio
Back to top